Home › Movement Disorders › Massachusetts › Boston
Movement Disorders clinical trials in Boston, MA
6 studies for Movement Disorders are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
RecruitingPhase 1/2
- Beth Israel Deaconess Medical Center, Boston
A Multicenter Pediatric Deep Brain Stimulation Registry
RecruitingObservational study
- Boston Children's Hospital, Boston
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RecruitingObservational study
- Boston Children's Hospital, Boston
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RecruitingObservational study
- Boston Children's Hospital, Boston
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
RecruitingObservational studyHealthy volunteers welcome
- Massachusetts General Hospital, Boston
Registry and Natural History of Epilepsy-Dyskinesia Syndromes
RecruitingObservational study
- Boston Children's Hospital, Boston
About Movement Disorders
Movement disorders can be caused by nerve diseases, autoimmune diseases, infections and more. Many movement disorders are inherited.
More about Movement Disorders on MedlinePlus
Movement Disorders trials in other cities
- Washington, DC7 studies
- Philadelphia, PA6 studies
- Pittsburgh, PA4 studies
- Baltimore, MD3 studies
- New York City, NY3 studies
- Los Angeles, CA3 studies
- Columbus, OH3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer61 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.